Related Experiment Video
Updated: May 5, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
Distinct gut microbiome profiles in Korean systemic lupus erythematosus patients
Youngjae Park1, Jiwon Yang1, Hahee Son2
1Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea.
Background:
Systemic lupus erythematosus (SLE) is an autoimmune disease associated with systemic inflammation and multi-organ involvement. Emerging evidence suggests that gut microbiota dysbiosis may contribute to its immunopathogenesis.
Objective:
This study aimed to characterize gut microbial composition and diversity in Korean SLE patients and evaluate associations with clinical features.
Methods:
Fecal samples from 157 SLE patients and 50 healthy controls (HC) were analyzed using 16S rRNA gene sequencing. Alpha and beta diversity metrics were assessed, and taxonomic differences were analyzed. Subgroup comparisons were conducted based on lupus nephritis (LN) status and disease activity. Functional predictions were inferred using PICRUSt2.
Results:
SLE patients exhibited significantly reduced microbial richness (Chao1, ACE, Fisher indices), while evenness (Shannon, Simpson) was preserved. Beta diversity analysis revealed distinct clustering between SLE and HC groups. SLE was characterized by enrichment of Bacteroides, Streptococcus, and Veillonella, and depletion of Collinsella, Ruminococcus, and Bifidobacterium. LEfSe identified several discriminatory taxa. However, no significant microbial differences were observed between LN-positive and LN-negative groups or between high and low disease activity groups. Functional prediction revealed minimal differences in microbial pathways between groups.
Conclusion:
These findings highlight distinct gut microbial alterations in Korean SLE patients and support the potential utility of microbiome profiles as diagnostic biomarkers or therapeutics.
Related Concept Videos
The Skin Microbiota
Microbiome of the Eye
Microbiota of the Stomach and Small Intestine
Microbiota of the Large Intestine
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations

